AMA Journal of Ethics®

Illuminating the art of medicine

Journal of Ethics Header

AMA Journal of Ethics®

Illuminating the art of medicine

Virtual Mentor. November 2010, Volume 12, Number 11: 839-907.

  • Print
  • |
  • View PDF

November 2010 Contents

Gray Matters: Neuroethics in the Twenty-First Century

Ethics Poll

Suppose a drug that is FDA-approved for treatment of narcolepsy has been found in widespread off-label use to help restore memory in older people who have age-associated memory loss (AAMI). Now the drug's manufacturer is performing clinical trials hoping to obtain FDA approval to market the drug for treatment of AAMI. Which of the following best describes how you think the drug should be used and why? The drug should be available:
A growing social movement considers behaviors associated with autism as expressions of healthy neurodiversity. Parents who are neurodiversity advocates decline medical interventions aimed at changing the autism-related behavior of their children. Which of the following best describes how you think the medical community should respond to those parents and why. Medicine should:
There is some correlation between extreme creativity and intelligence (e.g., Mozart, Picasso, Einstein), on the one hand, and eccentricity or difficulty in interacting socially with others, on the other hand.

From the Editor

Neurology in the Postmodern Era
Joshua Tompkins
Full Text | PDF
Virtual Mentor. 2010; 12:841-843.

Educating for Professionalism

Clinical Cases

Can Parents of a Child with Autism Refuse Treatment for Him?
Commentary by Margaret Moon
Full Text | PDF
Virtual Mentor. 2010; 12:844-848.

"Doc, I Need a Smart Pill"—Requests for Neurologic Enhancement
Commentary by Dan Larriviere
Full Text | PDF
Virtual Mentor. 2010; 12:849-853.

The Ethics of Diagnosing Nonepileptic Seizures with Placebo Infusion
Commentary by James L. Bernat
Full Text | PDF
Virtual Mentor. 2010; 12:854-859.

The Code Says

The AMA Code of Medical Ethics' Opinions on Using Drugs and Surgery for Purposes Other than Treatment
Full Text | PDF
Virtual Mentor. 2010; 12:860-863.

Journal Discussion

Guidelines for Prognostication and End-of-Life Decision Making for Newborns with Severe Neurologic Damage
Jay Desai
Full Text | PDF
Virtual Mentor. 2010; 12:864-866.

Clinical Pearl

The Spectrum of Autism—From Neuronal Connections to Behavioral Expression
Carla A. Mazefsky and Nancy J. Minshew
Full Text | PDF
Virtual Mentor. 2010; 12:867-872.

Law, Policy, and Society

Health Law

The Future of Neuroimaging in Witness Testimony
Benjamin Bumann
Full Text | PDF
Virtual Mentor. 2010; 12:873-878.

Policy Forum

Determining Brain Death—No Room for Error
James F. Bartscher and Panayiotis N. Varelas
Full Text | PDF
Virtual Mentor. 2010; 12:879-884.

Medicine and Society

Distinguishing between Restoration and Enhancement in Neuropharmacology
Peter B. Reiner
Full Text | PDF
Virtual Mentor. 2010; 12:885-888.

Op-Ed and Correspondence

Op-Ed

Perspective Taking and Advance Directives
Donna T. Chen
Full Text | PDF
Virtual Mentor. 2010; 12:893-897.

History, Art, and Narrative

Images of Healing and Learning

Images of the Creative Brain
Glenn R. Finney
Full Text | PDF
Virtual Mentor. 2010; 12:889-892.

Resources

Suggested Readings and Resources
PDF
Virtual Mentor. 2010; 12:898-904.

About the Contributors
Full Text | PDF
Virtual Mentor. 2010; 12:905-907.